Quantification of serum gp210 and sp100 antibodies in diagnosis of primary biliary cholangitis

被引：0
|
作者：
Mitova, T. [2 ]
Dimitrova, Y. [2 ]
Manolov, V. [2 ]
Vasilev, V. [1 ]
Popovska, T. [3 ]
Yunchova, V. [3 ]
Gerganov, M. [3 ]
Dimitrov, V. [2 ]
Angelov, T. [2 ]
机构：
[1] Med Lab Ramus, Sofia, Bulgaria
[2] Univ Hosp ISUL, Sofia, Bulgaria
[3] Univ Hosp St Anna, Sofia, Bulgaria
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118906
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P0569
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [1] Evaluation of serum SP100 antibodies in diagnosis of primary biliary cholangitis
    Manolov, V.
    Vasilev, V.
    Dimitrov, V.
    Dimitrova, Y.
    Mitova, T.
    Angelov, T.
    Popovska, T.
    Gerganov, M.
    Yunchova, S.
    CLINICA CHIMICA ACTA, 2024, 558 : 21 - 21
  • [2] Meta-Analysis Assessment of GP210 and SP100 for the Diagnosis of Primary Biliary Cirrhosis
    Hu, Shi-Ling
    Zhao, Feng-Rong
    Hu, Qin
    Chen, Wei-Xian
    PLOS ONE, 2014, 9 (07):
  • [3] GP210 AND/OR SP100 ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS: PREDICTORS OF CIRRHOSIS/AUTOIMMUNE (AIH) OVERLAP SYNDROMES?
    Taiwo, O.
    Mathew, S.
    Van Vlymen, J.
    Correa, A.
    Deacock, S. J.
    Berry, P.
    Cheent, K.
    Lewis, H.
    Ala, A.
    GUT, 2015, 64 : A263 - A263
  • [4] Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis
    Haldar, Debashis
    Janmohamed, Ashnila
    Plant, Tim
    Davidson, Matthew
    Norman, Hannah
    Russell, Emily
    Serevina, Olivia
    Chung, Kenneth
    Qamar, Kashif
    Gunson, Bridget
    Hansen, Bettina
    Richter, Alex
    Trivedi, Palak J.
    Hirschfield, Gideon M.
    LIVER INTERNATIONAL, 2021, 41 (03) : 535 - 544
  • [5] Antibodies to gp210 and Understanding Risk in Patients with Primary Biliary Cholangitis.
    Haldar, Debashis
    Janmohamed, Ashnila
    Plant, Tim
    Davidson, Matthew
    Norman, Hannah
    Russell, Emily
    Serevina, Olivia
    Chung, Kenneth
    Qamar, Kashif
    Gunson, Bridget
    Richter, Alex
    Hirschfield, Gideon
    HEPATOLOGY, 2018, 68 : 1096A - 1096A
  • [6] GP210 AND/OR SP100 AUTOANTIBODIES IN PRIMARY BILIARY CIRRHOSIS: PREDICTORS OF CIRRHOSIS/AUTOIMMUNE (AIH) OVERLAP SYNDROME?
    Taiwo, O.
    Mathew, S.
    Van Vlymen, J.
    Deacock, S.
    Ala, A.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S644 - S644
  • [7] The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis
    Luettig, B
    Boeker, KHW
    Schoessler, W
    Will, H
    Loges, S
    Schmidt, E
    Worman, HJ
    Gershwin, ME
    Manns, MP
    JOURNAL OF HEPATOLOGY, 1998, 28 (05) : 824 - 828
  • [8] Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis
    Ben Lamine, Zeineb
    Ben Jazia, Ilhem
    Ben Ahmed, Mariem
    Ben Slama, Ayda
    Baccouche, Azza
    Slama, Foued
    Jemaa, Ali
    Ghedira, Ibtissem
    Mankai, Amani
    ARAB JOURNAL OF GASTROENTEROLOGY, 2021, 22 (04) : 316 - 320
  • [9] The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China
    Chen, Qingling
    Zhong, Rui
    Dong, Kaihui
    Wang, Yao
    Kui, Yiwen
    Ma, Bo
    Wen, Xiaoyu
    Jin, Qinglong
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (08) : 1094 - 1100
  • [10] Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis
    Wang, Chan
    Qin, Zhuye
    Zhang, Mingming
    Dai, Yaping
    Zhang, Luyao
    Tian, Wenyan
    Gong, Yuhua
    Chen, Sufang
    Yang, Can
    Xu, Ping
    Shi, Xingjuan
    Zhao, Weifeng
    Timilsina, Suraj
    Gershwin, M. Eric
    Chen, Weichang
    Qiu, Fang
    Liu, Xiangdong
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2024, 8
12345